Fig. 9From: Validation of circulating histone detection by mass spectrometry for early diagnosis, prognosis, and management of critically ill septic patientsDecision thresholds according to levels of circulating histones H2B and H3 in plasma for early management of patients with sepsis. Values below 190 ng/mL for H2B are associated with increased survival probability. This result is reinforced if patients showed a value below 163 ng/mL of circulating histone H3. However, values higher than 190 ng/mL of H2B are associated with high risk of renal failure in septic shock patients and predictive of fatal outcome. When the levels of circulating histone H2B were higher than 335.50 ng/mL, there was an increased risk of developing DIC in patients. In line with this idea, we found that values for histone H2B above 435.61 ng/ml were indicative of need for vital support therapiesBack to article page